Unituxin Antibody Therapy
Unituxin is a monoclonal antibody that targets the GD2 antigen present on neuroblastoma cells.
Unituxin is one of the therapies used to treat children with high-risk neuroblastoma, a cancer that arises from immature nerve cells.
We developed the 3D style for “How Unituxin Works” — a video for parents and caregivers, designed in collaboration with the agency Dagr Nott & Associates.
Link to the animation and Unituxin website:
Neuroblastoma tumor cell and GD2 antigens – Style development
Antibody – Style development
Immune cells and Neuroblastoma cells – Style development
Threatening cell – Targeted by the immune system
Antibody and GD2 Antigen interaction
Neuron and GD2 Antigen – Style development